PDCD1 and neoplasm: For example, RT increases diffusion of immune cells into the tumor microenvironment allowing anti-tumor effects, while simultaneous anti-PD-L1, anti-PD1 and anti-CTLA-4 therapy can offset the immunosuppressive consequences induced by RT (90).